SCHEMBL4742855

SCHEMBL4742855

O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.75
SOST Q9BQB4 2/20 0.75
CYP1A2 P05177 2/20 0.75
ALOX15 P16050 2/20 0.75
HSD17B10 Q99714 2/20 0.75
MEN1 O00255 1/20 0.75
KMT2A Q03164 1/20 0.75
KDM4E B2RXH2 1/20 0.75
POLB P06746 1/20 0.75
GAA P10253 1/20 0.75
MAPT P10636 1/20 0.75
CYP3A4 P08684 1/20 0.75
ALOX12 P18054 1/20 0.75
NFKB1 P19838 1/20 0.75
MAPK1 P28482 1/20 0.75
HIF1A Q16665 1/20 0.75
KLK1 P06870 1/20 0.67
KLK3 P07288 1/20 0.67
KLK2 P20151 1/20 0.67
KLK7 P49862 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16263267 1.00 RECQL (0.75) RECQLSOSTCYP1A2ALOX15HSD17B10
SCHEMBL6360284 0.97 KLK1 (0.72) RECQLSOSTCYP1A2ALOX15HSD17B10
SCHEMBL29414343 0.97 KLK1 (0.72) RECQLSOSTCYP1A2ALOX15HSD17B10
SCHEMBL16263265 0.97 KLK1 (0.72) RECQLSOSTCYP1A2ALOX15HSD17B10
SCHEMBL6363033 0.92 KLK1 (0.66) RECQLSOSTCYP1A2ALOX15HSD17B10
SCHEMBL6360019 0.92 KLK1 (0.66) RECQLSOSTCYP1A2ALOX15HSD17B10
SCHEMBL28770111 0.92 KLK1 (0.66) RECQLSOSTCYP1A2ALOX15HSD17B10
SCHEMBL29441285 0.89 SOST (0.67) RECQLSOSTCYP1A2ALOX15HSD17B10
(+)-Taxifolin SCHEMBL296323 0.87 CYP3A4 (1.00) RECQLSOSTCYP1A2ALOX15HSD17B10
(+)-Taxifolin SCHEMBL7628142 0.87 CYP3A4 (1.00) RECQLSOSTCYP1A2ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11234918-B2 Methods for botanical and/or algae extraction BASF CORPORATION (US) 2022-02-01 US claimed
EP-2858641-B1 IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION BASF CORP (US) 2017-09-06 EP claimed
US-20150140141-A1 METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) 2015-05-21 US claimed
EP-2858641-A1 IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION BASF Corporation (US) 2015-04-15 EP claimed
WO-2013184884-A1 IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION BASF CORPORATION (US) 2013-12-12 WO claimed
US-20240245741-A1 EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL MINASOLVE SAS (FR) 2024-07-25 US disclosed
EP-4401852-A1 EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL Minasolve SAS (FR) 2024-07-24 EP disclosed
US-20230276836-A1 ORAL RETENTION COMPOSITION BIZEN CHEMICAL CO., LTD. (JP) 2023-09-07 US disclosed
WO-2023036973-A1 EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL MINASOLVE SAS (FR) 2023-03-16 WO disclosed
US-11234918-B2 Methods for botanical and/or algae extraction BASF CORPORATION (US) 2022-02-01 US disclosed
US-10981084-B2 Use of coconut water as extraction solvent BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) 2021-04-20 US disclosed
US-20190336884-A1 USE OF COCONUT WATER AS EXTRACTION SOLVENT BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) 2019-11-07 US disclosed
CN-110167527-A Use of coconut water as extraction solvent 巴斯夫美容护理法国公司 2019-08-23 CN disclosed
EP-2858641-B1 IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION BASF CORP (US) 2017-09-06 EP disclosed
US-20150140141-A1 METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) 2015-05-21 US disclosed
EP-2858641-A1 IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION BASF Corporation (US) 2015-04-15 EP disclosed
US-20140348966-A1 GARCINIA BUCHANANII BAKER COMPOUNDS, COMPOSITIONS AND RELATED METHODS THE REGENTS OF THE UNIVERSITY OF IDAHO 2014-11-27 US disclosed
WO-2013184884-A1 IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION BASF CORPORATION (US) 2013-12-12 WO disclosed
WO-2013096878-A1 GARCINIA BUCHANANII BAKER COMPOUNDS, COMPOSITIONS AND RELATED METHODS UNIVERSITY OF IDAHO (US) 2013-06-27 WO disclosed
WO-2008100977-A2 CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS N.V. ORGANON (NL) 2008-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11234918-B2 Methods for botanical and/or algae extraction ALG1, ALG8, CUTA RECQL 593/4885SOST 3463/4885CYP1A2 2550/4885
US-20150140141-A1 METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION ALG1, ALG8, CUTA RECQL 593/4885SOST 3463/4885CYP1A2 2550/4885
US-20140348966-A1 GARCINIA BUCHANANII BAKER COMPOUNDS, COMPOSITIONS AND RELATED METHODS GK, GMNN, GLA RECQL 224/4885SOST 1537/4885CYP1A2 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.